Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-20-003995
Filing Date
2020-04-17
Accepted
2020-04-17 14:27:07
Documents
4
Period of Report
2020-04-17

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20200417xpre14a.htm PRE 14A 1312931
2 GRAPHIC tmb-20200417xpre14ag001.jpg GRAPHIC 17645
3 GRAPHIC tmb-20200417xpre14ag002.gif GRAPHIC 90384
4 GRAPHIC tmb-20200417xpre14ag003.gif GRAPHIC 60141
  Complete submission text file 0001558370-20-003995.txt   1546055
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36576 | Film No.: 20799092
SIC: 2834 Pharmaceutical Preparations